Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study

Advanced glycation end products (AGEs) accumulate in fatty livers and may contribute to low-grade inflammation (LGI), potentially via their receptor, RAGE. It is unknown if the AGE accumulation in fatty livers results in elevated circulating AGEs. In a cohort study, we investigated the association o...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitchell Bijnen, Marleen M. J. van Greevenbroek, Carla J. H. van der Kallen, Jean L. Scheijen, Marjo P. H. van de Waarenburg, Coen D. A. Stehouwer, Kristiaan Wouters, Casper G. Schalkwijk
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2019/6289831
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551159389224960
author Mitchell Bijnen
Marleen M. J. van Greevenbroek
Carla J. H. van der Kallen
Jean L. Scheijen
Marjo P. H. van de Waarenburg
Coen D. A. Stehouwer
Kristiaan Wouters
Casper G. Schalkwijk
author_facet Mitchell Bijnen
Marleen M. J. van Greevenbroek
Carla J. H. van der Kallen
Jean L. Scheijen
Marjo P. H. van de Waarenburg
Coen D. A. Stehouwer
Kristiaan Wouters
Casper G. Schalkwijk
author_sort Mitchell Bijnen
collection DOAJ
description Advanced glycation end products (AGEs) accumulate in fatty livers and may contribute to low-grade inflammation (LGI), potentially via their receptor, RAGE. It is unknown if the AGE accumulation in fatty livers results in elevated circulating AGEs. In a cohort study, we investigated the association of liver fat and hepatocellular damage with circulating AGEs and soluble RAGE (sRAGE) and subsequently the association of circulating AGEs and sRAGE with LGI. Cross-sectional associations of liver fat percentage (eLF%; ln-transformed) and liver enzymes (LE score; standardized) with circulating AGEs (free CML, CEL, and MG-H1 in nM and protein-bound CML, CEL, and pentosidine in nmol/mmol lysine; ln-transformed) and sRAGE (pg/ml, ln-transformed) and additionally of AGEs and sRAGE with LGI (standardized) were determined by multiple linear regression. eLF% was positively associated with circulating free CEL (β=0.090; 95% CI 0.041; 0.139) but inversely with protein-bound CML (β=−0.071; 95% CI -0.108; -0.034). Similarly, the LE score was positively associated with free CML (β=0.044; 95% CI 0.012; 0.076) and CEL (β=0.040; 95% CI 0.009; 0.072) but inversely with protein-bound CML (β=−0.037; 95% CI -0.060; -0.013). Free CML (β=0.297; 95% CI 0.049; 0.545) was positively associated with LGI, while protein-bound CML (β=−0.547; 95% CI -0.888; -0.207) was inversely associated, although this association was absent after adjustment for BMI. eLF% and LE score were not associated with sRAGE and sRAGE not with LGI after adjustment for BMI. Liver fat and enzymes were positively associated with circulating free AGEs, which were associated with LGI. In contrast, inverse relations were observed of liver fat and enzymes with circulating protein-bound AGEs and of protein-bound AGEs with LGI. These data suggest that hepatic steatosis and inflammation affect the formation and degradation of hepatic protein-bound AGEs resulting in elevated circulating free AGE levels. These alterations in AGE levels might influence LGI, but this is likely independent of RAGE.
format Article
id doaj-art-009eb056902c40e5b87a3ba6266b9119
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-009eb056902c40e5b87a3ba6266b91192025-02-03T06:04:46ZengWileyJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/62898316289831Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM StudyMitchell Bijnen0Marleen M. J. van Greevenbroek1Carla J. H. van der Kallen2Jean L. Scheijen3Marjo P. H. van de Waarenburg4Coen D. A. Stehouwer5Kristiaan Wouters6Casper G. Schalkwijk7Department of Internal Medicine, MUMC, Maastricht, NetherlandsDepartment of Internal Medicine, MUMC, Maastricht, NetherlandsDepartment of Internal Medicine, MUMC, Maastricht, NetherlandsDepartment of Internal Medicine, MUMC, Maastricht, NetherlandsDepartment of Internal Medicine, MUMC, Maastricht, NetherlandsDepartment of Internal Medicine, MUMC, Maastricht, NetherlandsDepartment of Internal Medicine, MUMC, Maastricht, NetherlandsDepartment of Internal Medicine, MUMC, Maastricht, NetherlandsAdvanced glycation end products (AGEs) accumulate in fatty livers and may contribute to low-grade inflammation (LGI), potentially via their receptor, RAGE. It is unknown if the AGE accumulation in fatty livers results in elevated circulating AGEs. In a cohort study, we investigated the association of liver fat and hepatocellular damage with circulating AGEs and soluble RAGE (sRAGE) and subsequently the association of circulating AGEs and sRAGE with LGI. Cross-sectional associations of liver fat percentage (eLF%; ln-transformed) and liver enzymes (LE score; standardized) with circulating AGEs (free CML, CEL, and MG-H1 in nM and protein-bound CML, CEL, and pentosidine in nmol/mmol lysine; ln-transformed) and sRAGE (pg/ml, ln-transformed) and additionally of AGEs and sRAGE with LGI (standardized) were determined by multiple linear regression. eLF% was positively associated with circulating free CEL (β=0.090; 95% CI 0.041; 0.139) but inversely with protein-bound CML (β=−0.071; 95% CI -0.108; -0.034). Similarly, the LE score was positively associated with free CML (β=0.044; 95% CI 0.012; 0.076) and CEL (β=0.040; 95% CI 0.009; 0.072) but inversely with protein-bound CML (β=−0.037; 95% CI -0.060; -0.013). Free CML (β=0.297; 95% CI 0.049; 0.545) was positively associated with LGI, while protein-bound CML (β=−0.547; 95% CI -0.888; -0.207) was inversely associated, although this association was absent after adjustment for BMI. eLF% and LE score were not associated with sRAGE and sRAGE not with LGI after adjustment for BMI. Liver fat and enzymes were positively associated with circulating free AGEs, which were associated with LGI. In contrast, inverse relations were observed of liver fat and enzymes with circulating protein-bound AGEs and of protein-bound AGEs with LGI. These data suggest that hepatic steatosis and inflammation affect the formation and degradation of hepatic protein-bound AGEs resulting in elevated circulating free AGE levels. These alterations in AGE levels might influence LGI, but this is likely independent of RAGE.http://dx.doi.org/10.1155/2019/6289831
spellingShingle Mitchell Bijnen
Marleen M. J. van Greevenbroek
Carla J. H. van der Kallen
Jean L. Scheijen
Marjo P. H. van de Waarenburg
Coen D. A. Stehouwer
Kristiaan Wouters
Casper G. Schalkwijk
Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
Journal of Diabetes Research
title Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
title_full Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
title_fullStr Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
title_full_unstemmed Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
title_short Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
title_sort hepatic fat content and liver enzymes are associated with circulating free and protein bound advanced glycation end products which are associated with low grade inflammation the codam study
url http://dx.doi.org/10.1155/2019/6289831
work_keys_str_mv AT mitchellbijnen hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy
AT marleenmjvangreevenbroek hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy
AT carlajhvanderkallen hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy
AT jeanlscheijen hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy
AT marjophvandewaarenburg hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy
AT coendastehouwer hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy
AT kristiaanwouters hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy
AT caspergschalkwijk hepaticfatcontentandliverenzymesareassociatedwithcirculatingfreeandproteinboundadvancedglycationendproductswhichareassociatedwithlowgradeinflammationthecodamstudy